0

530317

GODAVARI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GODAVARI DRUGS LTD. Share Price Today

Investment Returns

Over 1 Month -5.65% Over 3 Months 47.53% Over 6 Months 69.08% Over 1 Year 24.54%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GODAVARI DRUGS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 126.60
  • P/E Ratio (TTM) 29.94
  • Beta 0.81
  • Book Value / share 69.65
  • Return on equity 10.64%
  • EPS (TTM) 3.75
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 1.29
info icon alternate text

GODAVARI DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 33.16
Operating Expense 31.80
Net Profit 1.29
Net Profit Margin (%) 3.89
Earnings Per Share (EPS) 1.71
EBITDA 3.19
Effective Tax Rate (%) 20.37
Particulars DEC 2025 (Values in Cr)
Revenue 22.18
Operating Expense 21.43
Net Profit 0.76
Net Profit Margin (%) 3.42
Earnings Per Share (EPS) 1.01
EBITDA 2.73
Effective Tax Rate (%) 25.49
Particulars SEP 2025 (Values in Cr)
Revenue 26.65
Operating Expense 26.17
Net Profit 1.00
Net Profit Margin (%) 3.75
Earnings Per Share (EPS) 1.33
EBITDA 2.63
Effective Tax Rate (%) 10.71
Particulars JUN 2025 (Values in Cr)
Revenue 23.81
Operating Expense 22.52
Net Profit 1.04
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 1.38
EBITDA 2.90
Effective Tax Rate (%) 20.00
Particulars MAR 2025 (Values in Cr)
Revenue 25.50
Operating Expense 24.16
Net Profit 0.89
Net Profit Margin (%) 3.49
Earnings Per Share (EPS) 1.19
EBITDA 3.21
Effective Tax Rate (%) 38.19
Particulars MAR 2026 (Values in Cr)
Revenue 105.81
Operating Expense 101.91
Net Profit 4.09
Net Profit Margin (%) 3.86
Earnings Per Share (EPS) 5.43
EBITDA 11.46
Effective Tax Rate (%) 19.16
Particulars MAR 2025 (Values in Cr)
Revenue 113.35
Operating Expense 108.70
Net Profit 4.38
Net Profit Margin (%) 3.86
Earnings Per Share (EPS) 5.82
EBITDA 12.80
Effective Tax Rate (%) 22.20
Particulars MAR 2024 (Values in Cr)
Revenue 156.71
Operating Expense 150.32
Net Profit 5.55
Net Profit Margin (%) 3.54
Earnings Per Share (EPS) 7.37
EBITDA 13.83
Effective Tax Rate (%) 19.79
Particulars MAR 2023 (Values in Cr)
Revenue 159.62
Operating Expense 155.58
Net Profit 3.79
Net Profit Margin (%) 2.37
Earnings Per Share (EPS) 5.03
EBITDA 10.79
Effective Tax Rate (%) 23.32
Particulars MAR 2022 (Values in Cr)
Revenue 161.11
Operating Expense 154.35
Net Profit 5.25
Net Profit Margin (%) 3.25
Earnings Per Share (EPS) 6.97
EBITDA 11.56
Effective Tax Rate (%) 25.35
Particulars MAR 2025 (Values in Cr)
Book Value / Share 57.56
ROE % 10.64
ROCE % 10.06
Total Debt to Total Equity 1.48
EBITDA Margin 11.29
Particulars MAR 2024 (Values in Cr)
Book Value / Share 51.74
ROE % 15.33
ROCE % 14.14
Total Debt to Total Equity 1.29
EBITDA Margin 8.83
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.38
ROE % 12.02
ROCE % 14.37
Total Debt to Total Equity 0.93
EBITDA Margin 6.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share 39.35
ROE % 19.44
ROCE % 18.12
Total Debt to Total Equity 0.99
EBITDA Margin 7.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 32.38
ROE % 18.50
ROCE % 17.34
Total Debt to Total Equity 1.30
EBITDA Margin 8.36
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.37
Total Assets 143.07
Total Liabilities 143.07
Total Equity 43.34
Share Outstanding 0
Price to Book Ratio 1.52
Return on Assets (%) 3.06
Return on Capital (%) 4.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.62
Total Assets 134.75
Total Liabilities 134.75
Total Equity 38.96
Share Outstanding 0
Price to Book Ratio 1.80
Return on Assets (%) 4.11
Return on Capital (%) 5.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.08
Total Assets 121.43
Total Liabilities 121.43
Total Equity 33.41
Share Outstanding 0
Price to Book Ratio 1.71
Return on Assets (%) 3.11
Return on Capital (%) 5.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.27
Total Assets 101.41
Total Liabilities 101.41
Total Equity 29.63
Share Outstanding 0
Price to Book Ratio 1.66
Return on Assets (%) 5.17
Return on Capital (%) 10.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 91.13
Total Liabilities 91.13
Total Equity 24.38
Share Outstanding 0
Price to Book Ratio 1.41
Return on Assets (%) 4.52
Return on Capital (%) 7.87
Particulars MAR 2025 (Values in Cr)
Net Income 12.80
Cash from Operations 12.35
Cash from Investing -19.51
Cash from Financing 8.06
Net change in Cash -0.24
Free Cash Flow 32.34
Particulars MAR 2024 (Values in Cr)
Net Income 13.83
Cash from Operations 19.43
Cash from Investing -13.22
Cash from Financing -5.65
Net change in Cash -0.46
Free Cash Flow 32.63
Particulars MAR 2023 (Values in Cr)
Net Income 10.80
Cash from Operations 14.36
Cash from Investing -8.63
Cash from Financing -3.77
Net change in Cash 0.80
Free Cash Flow 23.66
Particulars MAR 2022 (Values in Cr)
Net Income 11.56
Cash from Operations 13.00
Cash from Investing -4.97
Cash from Financing -5.62
Net change in Cash 0.63
Free Cash Flow 18.25
Particulars MAR 2021 (Values in Cr)
Net Income 10.23
Cash from Operations 2.90
Cash from Investing -1.25
Cash from Financing 0.13
Net change in Cash 0.21
Free Cash Flow 4.57
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 13.80 1.61 255.88 23.12 38.85
BLISS GVS PHARMA LTD. 439.70 35.69 3.90 4663.29 118.35 462.70
CIPLA LTD. 1381.50 29.32 3.24 111603.83 1165.55 1672.20
FERMENTA BIOTECH LTD. 328.70 14.50 2.37 967.40 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2124.65 37.41 15.87 35992.85 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 23.35 4.30 255.88 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 553.70 24.82 4.32 1600.78 490.00 789.95
ASTRAZENECA PHARMA IND LT 8425.15 110.03 24.13 21062.88 7630.00 10557.00
BLISS GVS PHARMA LTD. 439.70 47.43 4.03 4663.29 118.35 462.70

GODAVARI DRUGS LTD. shareholding pattern

Holding
57.3%
40.22%
2.46%
0.21%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GODAVARI DRUGS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
125.00 3.34 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 121.20
  • 26 Days 122.40
  • 10 Days 122.40
  • 50 Days 117.00
  • 12 Days 122.70
  • 100 Days 107.30
  • 20 Days 123.00
  • 200 Days 99.80
119.15 PIVOT
First Support 116.50 First Resistance 123.30 Second Support 112.35 Second Resistance 125.95 Third Support 109.70 Third Resistance 130.10
RSI 47.72 ADX 27.70 MACD 0.51 Williams % R -72.10 Commodity Channel Index (CCI) -185.15
Date 2026-06-15 Week 5174.00 Same Day 8160.00 Month 4966.00
1 Year 0.82 3 Year 0.61
Over 1 Month
-5.65% down
Over 1 Year
24.54% down
Over 3 Months
47.53% down
Over 3 Years
8.42% down
Over 6 Months
69.08% down
Over 5 Years
13.61% down

GODAVARI DRUGS LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Godavari Drugs Ltd?

Answer Field

Godavari Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 125.00 as on Jun 16 2026 01:33 PM.

What is the Market Cap of Godavari Drugs Ltd Share?

Answer Field

The market cap of Godavari Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 126.60 as on Jun 16 2026 01:33 PM.

What is the 52 Week High and Low of Godavari Drugs Ltd?

Answer Field

The 52 Week High and Low of Godavari Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 135.25 and ₹ 69.70.

What is 1 year return for Godavari Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 24.54%.

What is the P/E Ratio of Godavari Drugs Ltd Share?

Answer Field

As on Jun 16 2026 01:33 PM the price-to-earnings (PE) ratio for Godavari Drugs Ltd share is 29.94.

What is the PB ratio of Godavari Drugs Ltd Share?

Answer Field

As on Jun 16 2026 01:33 PM, the price-to-book (PB) ratio for Godavari Drugs Ltd share is 69.65.

How to Buy Godavari Drugs Ltd Share?

Answer Field

You can trade in Godavari Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Godavari Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Godavari Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Godavari Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|